Structure-function relationships of chimeric antigen receptors in acute T cell responses to antigen-Reference-Cited by-同舟云学术

Structure-function relationships of chimeric antigen receptors in acute T cell responses to antigen

Published:2020-10 Issue: Volume:126 Page:56-64
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Xu Han^ORCID,Hamburger Agnes E.^ORCID,Mock Jee-Young,Wang Xueyin,Martin Aaron D.^ORCID,Tokatlian Talar^ORCID,Oh Julyun,Daris Mark E.^ORCID,Negri Kathleen R.^ORCID,Gabrelow Grant B.^ORCID,Wu Ming Lun,Nampe Daniel P.,Asuelime Grace E.,McElvain Michele E.,Sandberg Mark L.^ORCID,Kamb Alexander

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference38 articles.

1. TCR reconstitution in Jurkat reporter cells facilitates the identification of novel tumor antigens by cDNA expression cloning;Aarnoudse;Int. J. Cancer,2002

2. Function of novel anti-CD19 chimeric antigen receptors with human variable regions is affected by hinge and transmembrane domains;Alabanza;Mol. Ther.,2017

3. Phenotypic analysis of antigen-specific T lymphocytes;Altman;Science,1996

4. Structure of a TCR-mimic antibody with target predicts pharmacogenetics;Ataie;J. Mol. Biol.,2016

5. Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells;Bossi;OncoImmunology,2013

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐throughput screen to identify and optimize NOT gate receptors for cell therapy;Cytometry Part A;2024-08-17

2. Immunotherapy Study on Non-small-Cell Lung Cancer (NSCLC) Combined with Cytotoxic T Cells and miRNA34a;Molecular Pharmaceutics;2024-01-31

3. Geometric parameters that affect the behavior of logic-gated CAR T cells;Frontiers in Immunology;2024-01-26

4. Complexities in comparing the impact of costimulatory domains on approved CD19 CAR functionality;Journal of Translational Medicine;2023-07-30

5. HLA-A∗02-gated safety switch for cancer therapy has exquisite specificity for its allelic target antigen;Molecular Therapy - Oncolytics;2022-12